Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update
Journal article published in 2024 by
Harold J. Burstein,
Angela DeMichele 
,
Lesley Fallowfield,
Mark R. Somerfield,
N. Lynn Henry,
N. Lynn Henry,
Zoneddy Dayao,
Anthony Elias,
Kevin Kalinsky,
Lisa M. McShane,
Beverly Moy,
Ben Ho Park,
Kelly M. Shanahan,
Priyanka Sharma,
Rebecca Shatsky
and other authors.
,
Lesley Fallowfield,
Mark R. Somerfield,
N. Lynn Henry,
N. Lynn Henry,
Zoneddy Dayao,
Anthony Elias,
Kevin Kalinsky,
Lisa M. McShane,
Beverly Moy,
Ben Ho Park,
Kelly M. Shanahan,
Priyanka Sharma,
Rebecca Shatsky
and other authors.
